Mankind Pharma to Acquire 100% Stake in Bharat Serums
Mankind Pharma is set to acquire 100% of Bharat Serums and Vaccines Limited for ₹13,630 crores to strengthen its position in women's health and critical care.
by Damodharan N
Updated Jul 26, 2024
Table of Content
Mankind Pharma Limited has announced a major acquisition deal, securing a 100% stake in Bharat Serums and Vaccines Limited (BSV). The Board of Directors approved the acquisition in a meeting held on July 25, 2024. The deal is subject to customary conditions and regulatory approvals.
Merger Details:
- Acquisition Date: July 25, 2024
- Entities Involved: Mankind Pharma, Bharat Serums and Vaccines Limited, and sellers Ansamira Limited and Miransa Limited (affiliates of Advent International), as well as minority shareholders Bhaskar Iyer and Abhijit Mukherjee.
- Enterprise Value: Approximately ₹13,630 Crores (subject to adjustments as per the Share Purchase Agreement).
- Percentage of Shareholding: Mankind Pharma will acquire 100% of BSV by purchasing 73,086 equity shares.
- Regulatory Approvals Required:
- Competition Commission of India (CCI)
- Turkish Competition Authority
- Federal Ministry of Economic Affairs and Climate Action, Germany
The primary reason for Mankind Pharma's acquisition of Bharat Serums and Vaccines Limited (BSV) is to expand into complex and high-barrier segments within the pharmaceutical industry. By integrating BSV, which specializes in women's health, fertility, critical care, and immunoglobulins.
Mankind Pharma aims to enhance its portfolio and solidify its position as a leader in the Indian market for women's health and fertility. This strategic move is intended to bolster Mankind Pharma's market presence and strengthen its capabilities in these specialized areas.
Source: Here
Mankind Pharma
Mankind Pharma, founded in 1991 and operational since 1995, is one of India's largest pharmaceutical companies by domestic sales. It develops, manufactures, and markets a wide range of pharmaceutical formulations for various therapeutic areas and consumer healthcare products.
The company, known for its strong presence in India, generated a revenue of ₹10,335 crore in FY24. With over 23,000 employees and a focus on providing quality products at affordable prices, Mankind Pharma has built and scaled numerous brands, including MANforce, Prega News, GAS O FAST, AcneStar, and HealthOK.
Bharat Serums
Bharat Serums and Vaccines Limited (BSV), founded in 1971, is a leading biopharmaceutical company in India dedicated to enhancing quality of life through innovative treatments. With a mission to improve health and save lives, BSV focuses on critical therapeutic areas such as women’s health, critical care, and IUI-IVF.
The company operates globally, with manufacturing and R&D facilities in India, Germany, and the US, and is present in over 70 countries. Known for its advanced research capabilities and adherence to global manufacturing practices, BSV is committed to bringing life-enhancing solutions to patients worldwide.
Mankind Pharma to Acquire 100% Stake in Bharat Serums - FAQs
1. What is Mankind Pharma acquiring?
Mankind Pharma is acquiring 100% of Bharat Serums and Vaccines Limited (BSV).
2. What is the value of the acquisition?
The acquisition is valued at approximately ₹13,630 crores.
3. When was the acquisition approved?
The acquisition was approved on July 25, 2024.
4. Who are the sellers in this deal?
Sellers include Ansamira Limited, Miransa Limited, Bhaskar Iyer, and Abhijit Mukherjee.
5. What approvals are required for the acquisition?
Approvals are needed from the Competition Commission of India, Turkish Competition Authority, and Federal Ministry of Economic Affairs, Germany.
6. What percentage of BSV will Mankind Pharma acquire?
Mankind Pharma will acquire 100% of BSV.
7. How many shares will Mankind Pharma purchase?
Mankind Pharma will purchase 73,086 equity shares.
8. What are the primary reasons for the acquisition?
To expand into women’s health, fertility, and critical care segments.
9. Where is Mankind Pharma based?
Mankind Pharma is based in India.
10. What is BSV known for?
BSV is known for its treatments in women’s health, critical care, and IUI-IVF.